
Keywords: CRC; colorectal cancer; DHA; docosahexaenoic acid; GI; gastrointestinal; GRAS; generally regarded as safe; HAHp; half-fin anchovy hydrolysates; HPMC; hydroxy propyl methyl cellulose; NLCs; nanostructured lipid carriers; SCFA; small chain fatty acid; SHIV;